We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $441K | ﹤0.01% |
+15,742
| New | +$438K |
|
2102
Central Garden & Pet Co Class A
CENTA
$2.38B
| $441K | ﹤0.01% |
13,348
+968
| +8% | +$34.9K |
|
2103
Suzano
SUZ
$9.72B
| $439K | ﹤0.01% |
42,718
+172
| +0.4% | +$1.81K |
|
2104
Relay Therapeutics
RLAY
$4.41B
| $438K | ﹤0.01% |
67,243
+52,693
| +362% | +$360K |
|
2105
POSCO
PKX
$17.3B
| $438K | ﹤0.01% |
6,668
-6
| -0.1% | -$425 |
|
2106
Conduent
CNDT
$242M
| $438K | ﹤0.01% |
134,256
+20,735
| +18% | +$70.5K |
|
2107
Sunrun
RUN
$2.42B
| $436K | ﹤0.01% |
+36,797
| New | +$451K |
|
2108
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
| $436K | ﹤0.01% |
+5,094
| New | +$420K |
|
2109
Cameco
CCJ
$42.8B
| $436K | ﹤0.01% |
8,855
-753
| -8% | -$38.2K |
|
2110
Red Rock Resorts
RRR
$3.7B
| $435K | ﹤0.01% |
7,920
+66
| +0.8% | +$3.58K |
|
2111
Encore Capital Group
ECPG
$1.98B
| $435K | ﹤0.01% |
+10,424
| New | +$450K |
|
|
ITOS
2112
DELISTED
iTeos Therapeutics
ITOS
| $435K | ﹤0.01% |
29,298
-56,870
| -66% | -$815K |
|
|
JBGS
2113
JBG SMITH
JBGS
$665M
| $434K | ﹤0.01% |
28,840
+14,787
| +105% | +$219K |
|
|
TWKS
2114
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $434K | ﹤0.01% |
152,790
+122,500
| +404% | +$328K |
|
2115
RELX
RELX
$61.8B
| $433K | ﹤0.01% |
+9,440
| New | +$410K |
|
|
OSG
2116
DELISTED
Overseas Shipholding Group Inc.
OSG
| $432K | ﹤0.01% |
50,885
+7,644
| +18% | +$55.4K |
|
2117
Standard BioTools
LAB
$314M
| $431K | ﹤0.01% |
243,237
+179,817
| +284% | +$440K |
|
2118
City Holding Co
CHCO
$2.06B
| $429K | ﹤0.01% |
4,038
+697
| +21% | +$71.6K |
|
2119
Vanda Pharmaceuticals
VNDA
$300M
| $429K | ﹤0.01% |
75,889
+48,945
| +182% | +$253K |
|
2120
ESCO Technologies
ESE
$7.78B
| $427K | ﹤0.01% |
4,065
-829
| -17% | -$87.4K |
|
2121
Anterix
ATEX
$1.85B
| $427K | ﹤0.01% |
10,779
+1,578
| +17% | +$51.1K |
|
2122
Aclaris Therapeutics
ACRS
$871M
| $425K | ﹤0.01% |
386,177
-226,028
| -37% | -$266K |
|
2123
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $424K | ﹤0.01% |
42,258
+11,100
| +36% | +$119K |
|
2124
MGE Energy Inc
MGEE
$3.05B
| $423K | ﹤0.01% |
5,659
-117
| -2% | -$9.14K |
|
2125
Orthofix Medical
OFIX
$427M
| $423K | ﹤0.01% |
31,863
+1,336
| +4% | +$18.3K |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.